Drew N. Maywar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Drew N. Maywar has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
- Govind Prasad Agrawal
University of Rochester
22 shared publications - Saif A. Al Graiti
IT research and development center, University of Kufa, Najaf, Iraq
6 shared publications A. Agarwal
Lucent Technol. Bell Labs, Holmdel, NJ, USA
5 shared publicationsD.F. Grosz
Lucent Technol. Bell Labs, Holmdel, NJ, USA
5 shared publicationsS. Banerjee
Lucent Technol. Bell Labs, Holmdel, NJ, USA
5 shared publications- Yuzhe Xiao
The Institute of Optics, University of Rochester, Rochester, New York 14627, USA
5 shared publications
Latest Publications
- Open Access
- 21 May 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (5) , 553
Analytical Basal-State Model of the Glucose, Insulin, and C-Peptide Systems for Type 2 Diabetes
We present a mechanistic mathematical model of the basal state for type 2 diabetes mellitus (T2DM) in an analytical form and illustrate its use for in silico basal-state and dynamic studies. At the core of the basal-state model is a quartic equation that expresses the basal plasma glucose concentration solely in terms of model parameters. This analytical model avoids a computationally intensive numerical solver and is illustrated by an investigation of how glucose-utilization parameters impact basal glucose, insulin, insulin-dependent utilization, and hepatic extraction, leveraging median parameter values of early-stage T2DM. Furthermore, the presented basal-state model ensures accurate execution of the corresponding dynamic model, which contains basal quantities within its derivative functions; erroneous, unintended dynamics in plasma glucose, insulin, and C-peptide are illustrated using an incorrect basal glucose value. The presented basal model enables efficient and accurate basal-state and dynamic studies, facilitating the understanding of T2DM pathophysiology and the development of T2DM diagnosis, treatment, and management strategies.
- 21 May 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (5) , 553
Open AccessAnalytical Basal-State Model of the Glucose, Insulin, and C-Peptide Systems for Type 2 Diabetes
We present a mechanistic mathematical model of the basal state for type 2 diabetes mellitus (T2DM) in an analytical form and illustrate its use for in silico basal-state and dynamic studies. At the core of the basal-state model is a quartic equation that expresses the basal plasma glucose concentration solely in terms of model parameters. This analytical model avoids a computationally intensive numerical solver and is illustrated by an investigation of how glucose-utilization parameters impact basal glucose, insulin, insulin-dependent utilization, and hepatic extraction, leveraging median parameter values of early-stage T2DM. Furthermore, the presented basal-state model ensures accurate execution of the corresponding dynamic model, which contains basal quantities within its derivative functions; erroneous, unintended dynamics in plasma glucose, insulin, and C-peptide are illustrated using an incorrect basal glucose value. The presented basal model enables efficient and accurate basal-state and dynamic studies, facilitating the understanding of T2DM pathophysiology and the development of T2DM diagnosis, treatment, and management strategies.
- Open Access
- 19 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0316035
Plasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration
Background: VEGF-A concentrations were measured in the blood of bevacizumab-treated cancer patients in previous studies, but a consensus has not formed that would develop VEGF-A into a clinical biomarker. Recently, methods to strictly distinguish between the VEGF-A isoforms have been developed but have not yet been applied to cancer patients undergoing bevacizumab treatment. Methods: An ELISA that strictly distinguishes between VEGF-A121 and VEGF-A165—the major isoforms of VEGF-A—and a commercially available ELISA for VEGF-A are used to determine the concentration of VEGF-A121, VEGF-A165, and VEGF-A in the blood of 12 patients with advanced colorectal cancer receiving bevacizumab therapy. Results: The serum and plasma concentrations of VEGF-A121 increased substantially post-bevacizumab administration; the median increase in serum was 860.8 pg/mL, 95% confidence interval (CI) [468.5, 1128.9], p = 0.0024, and in plasma was 808.6 pg/mL, 95% CI [748.7, 874.0], p = 0.00049. In stark contrast, VEGF-A165 after bevacizumab administration decreased in serum by a medium change of –73.8 pg/mL, 95% CI [–149.4, –10.2], p = 0.0034, with 83.3% of the post-bevacizumab concentrations falling below the high-accuracy threshold of 38 pg/mL; in plasma, all pre and post VEGF-A165 concentrations fell below this threshold. Concentrations of VEGF-A121 and VEGF-A165 in platelets did not change to a statistically significant degree. Adding recombinant VEGF-A121 (and -A165) or bevacizumab to plasma in patients post-bevacizumab administration increased or decreased, respectively, VEGF-A121 and VEGF-A165 levels. The increase in VEGF-A121 in plasma and serum after bevacizumab administration may be due to the dissociation of the complex of tumor-derived VEGF-A121 and bevacizumab when it moves from the stroma into the blood. Conclusions: The VEGF-A121 isoform has been uniquely demonstrated as a clear marker of bevacizumab therapy in both plasma and serum, motivating further research on pursuing these isoforms as biomarkers in cancer care.
- 19 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0316035
Open AccessPlasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration
Background: VEGF-A concentrations were measured in the blood of bevacizumab-treated cancer patients in previous studies, but a consensus has not formed that would develop VEGF-A into a clinical biomarker. Recently, methods to strictly distinguish between the VEGF-A isoforms have been developed but have not yet been applied to cancer patients undergoing bevacizumab treatment. Methods: An ELISA that strictly distinguishes between VEGF-A121 and VEGF-A165—the major isoforms of VEGF-A—and a commercially available ELISA for VEGF-A are used to determine the concentration of VEGF-A121, VEGF-A165, and VEGF-A in the blood of 12 patients with advanced colorectal cancer receiving bevacizumab therapy. Results: The serum and plasma concentrations of VEGF-A121 increased substantially post-bevacizumab administration; the median increase in serum was 860.8 pg/mL, 95% confidence interval (CI) [468.5, 1128.9], p = 0.0024, and in plasma was 808.6 pg/mL, 95% CI [748.7, 874.0], p = 0.00049. In stark contrast, VEGF-A165 after bevacizumab administration decreased in serum by a medium change of –73.8 pg/mL, 95% CI [–149.4, –10.2], p = 0.0034, with 83.3% of the post-bevacizumab concentrations falling below the high-accuracy threshold of 38 pg/mL; in plasma, all pre and post VEGF-A165 concentrations fell below this threshold. Concentrations of VEGF-A121 and VEGF-A165 in platelets did not change to a statistically significant degree. Adding recombinant VEGF-A121 (and -A165) or bevacizumab to plasma in patients post-bevacizumab administration increased or decreased, respectively, VEGF-A121 and VEGF-A165 levels. The increase in VEGF-A121 in plasma and serum after bevacizumab administration may be due to the dissociation of the complex of tumor-derived VEGF-A121 and bevacizumab when it moves from the stroma into the blood. Conclusions: The VEGF-A121 isoform has been uniquely demonstrated as a clear marker of bevacizumab therapy in both plasma and serum, motivating further research on pursuing these isoforms as biomarkers in cancer care.
- Open Access
The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer
Background/Objectives: The response rate to immune checkpoint inhibitor (ICI) therapy is limited. Further, there is a need to discover biomarkers to predict therapeutic efficacy. The vascular endothelial growth factor (VEGF) is strongly associated with intra-tumoral immunity; however, its utility as a marker remains unknown. Therefore, our objectives were to examine the isoforms of VEGF and determine whether VEGF levels predict ICI efficacy. Methods: Levels of VEGF isoforms VEGF-A121 and VEGF-A165 were measured in stored serum samples obtained from 30 patients with advanced or recurrent gastric cancer who received nivolumab monotherapy at Kagoshima University Hospital, and the association with prognosis and treatment efficacy was retrospectively analyzed. Results: The serum levels of the total VEGF, VEGF-A121, and VEGF-A165 were not significantly associated with prognosis. However, the ratio of VEGF-A121/VEGF-A165 (VEGF-A121/165) exhibited a statistically significant (p = 0.0088) difference in progression-free survival (PFS) with the low-ratio group having a 67-day prolonged median PFS time. Under univariable analysis, only VEGF-A121/165 values exhibited reduced progression-free survival with statistical significance. When comparing treatment responses in the low (n = 15) and high (n = 15) serum VEGF-A-121/165 groups, RECIST evaluation was 3 to 0 for complete response (CR), 2 to 0 for partial response (PR), 3 to 2 for stable disease (SD), and 3 to 10 for progressive disease (PD). Patients with clinically unsettled PR or SD were classified as non-CR/non-PD (4 vs. 3), with a disease control rate of 80% vs. 33%. Conclusions: The serum VEGF-A121/165 ratio may represent a new, easily measured biomarker for predicting the therapeutic response to ICIs.
Open AccessThe Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer
Background/Objectives: The response rate to immune checkpoint inhibitor (ICI) therapy is limited. Further, there is a need to discover biomarkers to predict therapeutic efficacy. The vascular endothelial growth factor (VEGF) is strongly associated with intra-tumoral immunity; however, its utility as a marker remains unknown. Therefore, our objectives were to examine the isoforms of VEGF and determine whether VEGF levels predict ICI efficacy. Methods: Levels of VEGF isoforms VEGF-A121 and VEGF-A165 were measured in stored serum samples obtained from 30 patients with advanced or recurrent gastric cancer who received nivolumab monotherapy at Kagoshima University Hospital, and the association with prognosis and treatment efficacy was retrospectively analyzed. Results: The serum levels of the total VEGF, VEGF-A121, and VEGF-A165 were not significantly associated with prognosis. However, the ratio of VEGF-A121/VEGF-A165 (VEGF-A121/165) exhibited a statistically significant (p = 0.0088) difference in progression-free survival (PFS) with the low-ratio group having a 67-day prolonged median PFS time. Under univariable analysis, only VEGF-A121/165 values exhibited reduced progression-free survival with statistical significance. When comparing treatment responses in the low (n = 15) and high (n = 15) serum VEGF-A-121/165 groups, RECIST evaluation was 3 to 0 for complete response (CR), 2 to 0 for partial response (PR), 3 to 2 for stable disease (SD), and 3 to 10 for progressive disease (PD). Patients with clinically unsettled PR or SD were classified as non-CR/non-PD (4 vs. 3), with a disease control rate of 80% vs. 33%. Conclusions: The serum VEGF-A121/165 ratio may represent a new, easily measured biomarker for predicting the therapeutic response to ICIs.
- 1 July 2024
- Published by IOP Publishing in Japanese Journal of Applied Physics
- Vol. 63 (7) , 072003
Photonic fan-out and local selectable inversion of the optical hysteresis shape
We demonstrate and elucidate the local selectable inversion of the hysteresis shape of a bistable optical signal after fan-out. This selectability is based on a hysteresis-shape transformation that yields a switching contrast over 20 dB in magnitude for both the inversion clockwise (CW) and the non-inversion counterclockwise (CCW) hysteresis shapes, while maintaining input-switching powers. This behavior leverages an initial signal whose bistability is manifested by its state of polarization; a generalized Malus’ law elucidates how selection is possible by controlling the transmittivity hysteresis through each local polarizer. The concept is demonstrated using a Fabry–Pérot semiconductor optical amplifier to produce the initial bistable polarization-rotating signal, followed by a 1 × 2 fan-out and the realization of all four hysteresis shapes at each location, independent of the other location. This fan-out and selectable inversion behavior is applicable to other nonlinear photonic systems and provides new functionality for parallel optical processing.
- 1 July 2024
- Published by IOP Publishing in Japanese Journal of Applied Physics
- Vol. 63 (7) , 072003
Photonic fan-out and local selectable inversion of the optical hysteresis shape
We demonstrate and elucidate the local selectable inversion of the hysteresis shape of a bistable optical signal after fan-out. This selectability is based on a hysteresis-shape transformation that yields a switching contrast over 20 dB in magnitude for both the inversion clockwise (CW) and the non-inversion counterclockwise (CCW) hysteresis shapes, while maintaining input-switching powers. This behavior leverages an initial signal whose bistability is manifested by its state of polarization; a generalized Malus’ law elucidates how selection is possible by controlling the transmittivity hysteresis through each local polarizer. The concept is demonstrated using a Fabry–Pérot semiconductor optical amplifier to produce the initial bistable polarization-rotating signal, followed by a 1 × 2 fan-out and the realization of all four hysteresis shapes at each location, independent of the other location. This fan-out and selectable inversion behavior is applicable to other nonlinear photonic systems and provides new functionality for parallel optical processing.
- 23 June 2023
- Published by Optica Publishing Group in Journal of the Optical Society of America B
- Vol. 40 (7) , 1815-1829
Analytical model of direct-Bragg, exchange-Bragg, and evanescent coupling in a dual-waveguide structure and its application to single-mode lasing
Single-mode distributed-feedback lasing is explored for an asynchronous dual-waveguide uniform-grating structure that exhibits exchange-Bragg and evanescent coupling between optical modes of the two waveguides as well as direct-Bragg coupling between optical modes within each waveguide. Coupled-mode equations governing all coupling processes are presented and solved, yielding an analytical solution that is applicable to a variety of single-mode lasing mechanisms. We leverage this solution to elucidate the lasing mechanism in which the photonic bandgap (PBG) due to exchange-Bragg coupling is aligned to and suppresses a degenerate lasing mode associated with the direct-Bragg PBG of the active waveguide. PBG alignment and mode suppression are achieved for a range of values of Henry’s alpha, direct-Bragg coupling, exchange-Bragg coupling, and evanescent coupling that yield at-threshold gain margin and longitudinal power flatness superior to those of the benchmark λ/4-shifted DFB lasing structure. Such performance includes a gain margin ΔαL=0.88 for a minimum flatness F=0.0006, enabled by the power-transfer action of evanescent coupling. The dual-waveguide geometry and superior predicted performance make the structure compelling for both III-V and heterogeneous III-V-on-silicon platforms.
- 23 June 2023
- Published by Optica Publishing Group in Journal of the Optical Society of America B
- Vol. 40 (7) , 1815-1829
Analytical model of direct-Bragg, exchange-Bragg, and evanescent coupling in a dual-waveguide structure and its application to single-mode lasing
Single-mode distributed-feedback lasing is explored for an asynchronous dual-waveguide uniform-grating structure that exhibits exchange-Bragg and evanescent coupling between optical modes of the two waveguides as well as direct-Bragg coupling between optical modes within each waveguide. Coupled-mode equations governing all coupling processes are presented and solved, yielding an analytical solution that is applicable to a variety of single-mode lasing mechanisms. We leverage this solution to elucidate the lasing mechanism in which the photonic bandgap (PBG) due to exchange-Bragg coupling is aligned to and suppresses a degenerate lasing mode associated with the direct-Bragg PBG of the active waveguide. PBG alignment and mode suppression are achieved for a range of values of Henry’s alpha, direct-Bragg coupling, exchange-Bragg coupling, and evanescent coupling that yield at-threshold gain margin and longitudinal power flatness superior to those of the benchmark λ/4-shifted DFB lasing structure. Such performance includes a gain margin ΔαL=0.88 for a minimum flatness F=0.0006, enabled by the power-transfer action of evanescent coupling. The dual-waveguide geometry and superior predicted performance make the structure compelling for both III-V and heterogeneous III-V-on-silicon platforms.
- 29 June 2022
- Published by Optica Publishing Group in Optics Letters
- Vol. 47 (13) , 3367-3370
Single-mode distributed feedback lasing using photonic bandgaps to suppress degenerate modes
We present a method for achieving single-mode distributed feedback lasing, using photonic bandgaps (PBGs) to suppress degenerate lasing modes. These PBGs arise from direct-Bragg coupling and exchange-Bragg coupling due to a passive waveguide placed in proximity to a uniform-grating–active-waveguide lasing structure. Analytic solutions at lasing threshold for this dual-waveguide, four-port structure reveal a high normalized gain margin (e.g., ΔαL = 0.86) accompanied by a low power flatness (e.g., F = 0.001) along the active region, outperforming the λ/4-shifted DFB laser structure. This single-mode lasing mechanism is compelling for both III/V and III/V-on-silicon platforms.
- 29 June 2022
- Published by Optica Publishing Group in Optics Letters
- Vol. 47 (13) , 3367-3370
Single-mode distributed feedback lasing using photonic bandgaps to suppress degenerate modes
We present a method for achieving single-mode distributed feedback lasing, using photonic bandgaps (PBGs) to suppress degenerate lasing modes. These PBGs arise from direct-Bragg coupling and exchange-Bragg coupling due to a passive waveguide placed in proximity to a uniform-grating–active-waveguide lasing structure. Analytic solutions at lasing threshold for this dual-waveguide, four-port structure reveal a high normalized gain margin (e.g., ΔαL = 0.86) accompanied by a low power flatness (e.g., F = 0.001) along the active region, outperforming the λ/4-shifted DFB laser structure. This single-mode lasing mechanism is compelling for both III/V and III/V-on-silicon platforms.
- Open Access
- 11 April 2022
- Published by Institution of Engineering and Technology (IET) in Electronics Letters
- Vol. 58 (11) , 439-441
Selectable microwave‐frequency doubling and quadrupling via optical path‐length tuning
A technique to selectively double or quadruple the frequency of a microwave signal is experimentally demonstrated based on a commercial single‐output Mach–Zehnder modulator (MZM). Selectability is achieved by only a change in optical path length in a post‐MZM optical subsystem, without filtering and without changing the MZM drive voltage. This path length controls the synchronisation of two similarly shaped optical signals that are incoherently combined. Multiplication from 2 GHz (S‐band) to 4 GHz (C‐band, doubling) and to 8 GHz (X‐band, quadrupling) is demonstrated with side‐tone suppression greater than 24 dB. At a 10‐kHz offset from the quadrupled frequency, the phase‐noise degradation is only 7.9 dB, a 4.1‐dB improvement over traditional quadrupling techniques.
- 11 April 2022
- Published by Institution of Engineering and Technology (IET) in Electronics Letters
- Vol. 58 (11) , 439-441
Open AccessSelectable microwave‐frequency doubling and quadrupling via optical path‐length tuning
A technique to selectively double or quadruple the frequency of a microwave signal is experimentally demonstrated based on a commercial single‐output Mach–Zehnder modulator (MZM). Selectability is achieved by only a change in optical path length in a post‐MZM optical subsystem, without filtering and without changing the MZM drive voltage. This path length controls the synchronisation of two similarly shaped optical signals that are incoherently combined. Multiplication from 2 GHz (S‐band) to 4 GHz (C‐band, doubling) and to 8 GHz (X‐band, quadrupling) is demonstrated with side‐tone suppression greater than 24 dB. At a 10‐kHz offset from the quadrupled frequency, the phase‐noise degradation is only 7.9 dB, a 4.1‐dB improvement over traditional quadrupling techniques.
- 3 December 2021
- Published by Optica Publishing Group in Journal of the Optical Society of America B
- Vol. 39 (1) , 9-21
Optical hysteresis shape transformation using linear polarization components
We provide a mathematical model to elucidate how a linear polarizer can be used to transform the shape of an optical-power hysteresis curve into the canonical counterclockwise (CCW) shape, clockwise (CW) shape, and upward-switching and downward-switching butterfly shapes. This transformation is possible for optical signals whose states of polarization also exhibit hysteresis. Critical to our model is a generalized Malus' law that accounts for elliptical input polarization as well as insertion loss, finite extinction ratio, and pass-axis orientation angle of the linear polarizer. The generalized Malus' law reveals that the transmittivity of the polarizer itself exhibits a bistable hysteresis curve, and this transmittivity acts on the input-power hysteresis curve to produce the variety of output-power shapes. Additionally, we model the optimization of the hysteresis contrast of the CCW and CW shapes, achieving 20 dB or more by using a polarization controller placed upstream of the polarizer. Modeling and experimental validation are carried out using a polarization-varying bistable signal generated by an anisotropic Fabry–Perot semiconductor optical amplifier, and the results are applicable to other nonlinear resonators and means of polarization-varying signal generation. This model can be used for the study, design, and optimization of a variety of sequential and combinational all-optical signal processing applications.
- 3 December 2021
- Published by Optica Publishing Group in Journal of the Optical Society of America B
- Vol. 39 (1) , 9-21
Optical hysteresis shape transformation using linear polarization components
We provide a mathematical model to elucidate how a linear polarizer can be used to transform the shape of an optical-power hysteresis curve into the canonical counterclockwise (CCW) shape, clockwise (CW) shape, and upward-switching and downward-switching butterfly shapes. This transformation is possible for optical signals whose states of polarization also exhibit hysteresis. Critical to our model is a generalized Malus' law that accounts for elliptical input polarization as well as insertion loss, finite extinction ratio, and pass-axis orientation angle of the linear polarizer. The generalized Malus' law reveals that the transmittivity of the polarizer itself exhibits a bistable hysteresis curve, and this transmittivity acts on the input-power hysteresis curve to produce the variety of output-power shapes. Additionally, we model the optimization of the hysteresis contrast of the CCW and CW shapes, achieving 20 dB or more by using a polarization controller placed upstream of the polarizer. Modeling and experimental validation are carried out using a polarization-varying bistable signal generated by an anisotropic Fabry–Perot semiconductor optical amplifier, and the results are applicable to other nonlinear resonators and means of polarization-varying signal generation. This model can be used for the study, design, and optimization of a variety of sequential and combinational all-optical signal processing applications.
- 1 January 2021
- Published by Optica Publishing Group
- p. NF2A.4
Distribution and simultaneous local control of the optical hysteresis shape
We experimentally demonstrate the distribution of a bistable optical signal to two locations, and then independently and simultaneously control the hysteresis shape at each location using local sets of linear optical components.
- 1 January 2021
- Published by Optica Publishing Group
- p. NF2A.4
Distribution and simultaneous local control of the optical hysteresis shape
We experimentally demonstrate the distribution of a bistable optical signal to two locations, and then independently and simultaneously control the hysteresis shape at each location using local sets of linear optical components.
- Open Access
- 18 December 2019
- Published by Optica Publishing Group in Optics Express
- Vol. 27 (26) , 38404-38412
Downstream hysteresis-shape control of a bistable optical signal created by an upstream nonlinear photonic resonator
We experimentally demonstrate the control of the hysteresis shape of a bistable optical signal at a location downstream of the nonlinear photonic resonator within which the bistability is generated. The downstream shape-control element consists of a fiber-optic polarization controller and linear polarizer in series, and the nonlinear resonator generates an optical signal whose bistable branches exhibit different states of power and polarization. The diversity of demonstrated hysteresis shapes include the canonical counter-clockwise shape (S-shape), the clockwise shape (inverted S-shape), and butterfly shapes; since all shapes originate from the same bistable signal, all shapes exhibit the same switching input powers. Moreover, the shape-selection process enhances the bistable switching contrast to 20 & 21 dB for the CCW and CW shapes, respectively. The shape-selection technique is demonstrated using a Fabry-Perot semiconductor optical amplifier, is applicable to other nonlinear photonic resonators, and provides flexibility to future combinational & sequential all-optical signal processing applications.
- 18 December 2019
- Published by Optica Publishing Group in Optics Express
- Vol. 27 (26) , 38404-38412
Open AccessDownstream hysteresis-shape control of a bistable optical signal created by an upstream nonlinear photonic resonator
We experimentally demonstrate the control of the hysteresis shape of a bistable optical signal at a location downstream of the nonlinear photonic resonator within which the bistability is generated. The downstream shape-control element consists of a fiber-optic polarization controller and linear polarizer in series, and the nonlinear resonator generates an optical signal whose bistable branches exhibit different states of power and polarization. The diversity of demonstrated hysteresis shapes include the canonical counter-clockwise shape (S-shape), the clockwise shape (inverted S-shape), and butterfly shapes; since all shapes originate from the same bistable signal, all shapes exhibit the same switching input powers. Moreover, the shape-selection process enhances the bistable switching contrast to 20 & 21 dB for the CCW and CW shapes, respectively. The shape-selection technique is demonstrated using a Fabry-Perot semiconductor optical amplifier, is applicable to other nonlinear photonic resonators, and provides flexibility to future combinational & sequential all-optical signal processing applications.